Table 1.
Baseline characteristics of the studies included in meta-analysis
| Gary et al 200416 |
Kitzman et al 201017 |
Edelmann et al 201118 |
Smart et al 201220 |
Alves et al 201219 |
Kitzman et al 201321 |
|
|---|---|---|---|---|---|---|
| Total participants (control/training) |
16/16 | 27/26 | 20/44 | 13/12 | 11/20 | 31/32 |
| Women (%) | 100 | 75 | 36 | 48 | 29 | 76 |
| Caucasian (%) | 59 | 70 | NA | NA | NA | 68 |
| Mean age, years | 68 ± 11 | 69.5 ± 5.5 | 65 ± 7 | 64.4 ± 6.4 | 62.9 ±10.2 | 70 ± 7 |
| Mean Body mass index, Kg/m2 |
33.5 ± 6.5 | 0.5 ± 6.5 | 31 ± 5 | 32.1 ± 6.4 | 28.4 ± 4.5 | 32.1 ± 6.6 |
| NYHA Class II (%) NYHA Class III (%) |
41 59 |
51 21 |
84 16 |
64 0 |
39 55 |
51 49 |
| Hypertension (%) | 88 | 68 | 86 | 16 | 68 | 89 |
| Diabetes (%) | 31 | 17 | 14 | 16 | 35 | 24 |
| Baseline Systolic BP, mm Hg |
NA | 147± 20 | 140 ± 19 | 131±11 | NA | 146 ± 17 |
| Baseline Heart Rate, beats/min |
NA | 69 ± 13 | 66 ± 11 | NA | NA | NA |
| Presentation EF (%) | ≥ 45 | ≥ 50 | ≥ 50 | ≥ 45 | ≥ 55 | ≥ 50 |
| Exercise capacity Assessment |
6 min walk test |
Cycle Ergometer |
Cycle Ergometer |
Cycle Ergometer |
Exercise treadmill test |
Cycle Ergometer |
| 6 min walk at baseline, feet |
832 ± 366 | 1452 ± 332 | 1794 ± 282 | NA | NA | 1450 ± 300 |
| Peak oxygen uptake baseline, ml/kg/min |
NA | 13.3 ± 2.6 | 16.3 ± 4.8 | 13.2 ± 3.9 | 13.6 ± 4.9 | 14.1± 3.0 |
| Blinded assessment of outcomes |
No | Yes | Yes | Yes | Yes | Yes |
NYHA: New York Heart Association; BP: Blood Pressure; EF: Ejection Fraction; Data represented as mean ± SD